These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36525477)

  • 21. Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis.
    O'Reilly SA; Roedica J; Nagy D; Hallewell RA; Alderson K; Marklund SL; Kuby J; Kushner PD
    Exp Neurol; 1995 Feb; 131(2):203-10. PubMed ID: 7895821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A susceptibility-weighted imaging qualitative score of the motor cortex may be a useful tool for distinguishing clinical phenotypes in amyotrophic lateral sclerosis.
    Conte G; Sbaraini S; Morelli C; Casale S; Caschera L; Contarino VE; Scola E; Cinnante C; Trogu F; Triulzi F; Silani V
    Eur Radiol; 2021 Mar; 31(3):1281-1289. PubMed ID: 32886203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases.
    Plantone D; Stufano A; Righi D; Locci S; Iavicoli I; Lovreglio P; De Stefano N
    Sci Rep; 2024 Mar; 14(1):6429. PubMed ID: 38499607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance.
    Katisko K; Cajanus A; Huber N; Jääskeläinen O; Kokkola T; Kärkkäinen V; Rostalski H; Hartikainen P; Koivisto AM; Hannonen S; Lehtola JM; Korhonen VE; Helisalmi S; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E; Haapasalo A
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1305-1312. PubMed ID: 34187866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases.
    Kim SH; Gwak HS; Lee Y; Park NY; Han M; Kim Y; Kim SY; Kim HJ
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid-refractory multiple sclerosis relapses.
    Vardakas I; Dorst J; Huss A; Mayer B; Fangerau T; Taranu D; Tumani H; Senel M
    Eur J Neurol; 2024 Aug; 31(8):e16323. PubMed ID: 38700322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients.
    Barro C; Healy BC; Saxena S; Glanz BI; Paul A; Polgar-Turcsanyi M; Guttmann CR; Bakshi R; Weiner HL; Chitnis T
    Mult Scler; 2023 Feb; 29(2):206-211. PubMed ID: 36448331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity.
    Bose G; Healy BC; Saxena S; Saleh F; Glanz BI; Bakshi R; Weiner HL; Chitnis T
    Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37813595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis.
    Loonstra FC; de Ruiter LRJ; Koel-Simmelink MJA; Schoonheim MM; Strijbis EMM; Moraal B; Barkhof F; Uitdehaag BMJ; Teunissen C; Killestein J
    Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36543540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis.
    Yalachkov Y; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Schaller-Paule MA
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36316116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional limitation of the masticatory system in patients with bulbar involvement in amyotrophic lateral sclerosis.
    Riera-Punet N; Martinez-Gomis J; Willaert E; Povedano M; Peraire M
    J Oral Rehabil; 2018 Mar; 45(3):204-210. PubMed ID: 29240971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis.
    Riku Y; Atsuta N; Yoshida M; Tatsumi S; Iwasaki Y; Mimuro M; Watanabe H; Ito M; Senda J; Nakamura R; Koike H; Sobue G
    BMJ Open; 2014 May; 4(5):e005213. PubMed ID: 24833696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
    Aktas O; Smith MA; Rees WA; Bennett JL; She D; Katz E; Cree BAC;
    Ann Neurol; 2021 May; 89(5):895-910. PubMed ID: 33724534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.
    Nakane S; Fujita K; Azuma S; Urushihara R; Kamada M; Harada M; Izumi Y; Kaji R
    Clin Neurol Neurosurg; 2018 Sep; 172():162-168. PubMed ID: 30016754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis.
    Mastrangelo A; Vacchiano V; Zenesini C; Ruggeri E; Baiardi S; Cherici A; Avoni P; Polischi B; Santoro F; Capellari S; Liguori R; Parchi P
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of glial fibrillary acidic protein (GFAP) in body fluids as a potential biomarker for glioma: a systematic review and meta-analysis.
    van Asperen JV; Fedorushkova DM; Robe PAJT; Hol EM
    Biomarkers; 2022 Feb; 27(1):1-12. PubMed ID: 34844498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre- and early postoperative GFAP serum levels in glioma and brain metastases.
    Baumgarten P; Quick-Weller J; Gessler F; Wagner M; Tichy J; Forster MT; Foerch C; Seifert V; Mittelbronn M; Senft C
    J Neurooncol; 2018 Sep; 139(3):541-546. PubMed ID: 29797180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome.
    Plantone D; Sabatelli E; Locci S; Marrodan M; Laakso SM; Mateen FJ; Feresiadou A; Buelens T; Bianco A; Fiol MP; Correale J; Tienari P; Calabresi P; De Stefano N; Iorio R
    Eur J Neurol; 2023 Oct; 30(10):3256-3264. PubMed ID: 37335505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.
    Lachén-Montes M; Mendizuri N; Ausin K; Andrés-Benito P; Ferrer I; Fernández-Irigoyen J; Santamaría E
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.